GlassScriptPhysician profile
Jose A Rivera
NPI 1902864333
$1,559.00
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $55.10 · 2021: $245 · 2022: $522 · 2023: $75.86 · 2024: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $450.05 | 2021-2024 | Renasys Go V2 Home, Regranex, Collagenase Santyl |
| Stryker Corporation | $203.42 | 2022 | |
| Organogenesis INC. | $182.02 | 2021-2022 | |
| Abbott Laboratories | $177.23 | 2020-2023 | Proclaim |
| Integra Lifesciences Corporation | $149.50 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kci USA, INC. | $105.17 | 2019-2023 | Activ.A.C. |
| Reflow Medical INC | $103.69 | 2024 | |
| Paragon 28, INC. | $95.95 | 2024 | Bone Marrow Aspirate Kit |
| Misonix INC | $43.37 | 2019 | |
| Viiv Healthcare Company | $33.91 | 2020 | |
| Abbvie INC. | $14.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.